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Regio and stereocontrolled syntheses of novel nitrophenyl analogues
of antihyperglycaemic N-sulphonyl-1a,2,6,6a-tetrahydro-1H,4H-1,3-
dioxepino5,6-bazirines: N-nitrobenzenesulphonylcycloheptabazi-
rine 6, N-nitrobenzenesulphonyldioxepinoazirines 7–10, N-nitro-
benzoyldioxepinoazirine 11 and N-nitrobenzyldioxepinoazirine 12,
starting from cycloheptene (2), trans-6-acetylamino-2-isopropyl-5-
chloro-1,3-dioxepane (13) and 5,6-epoxy-1,3-dioxepane (14), are de-
scribed. Their crystallographic data show that: (a) boat-chair (BC)
conformation of dioxepinoazirine and cycloheptabazirine moieties
dominates; (b) the substituent on aziridine nitrogen is always in
trans and never in cis position in relation to the cycloheptane or
dioxepane ring; (c) the sulphonyl group of sulphonylaziridines 6
and 8–10 adopts only one of the two possible conformations in rela-
tion to the aziridine ring, with torsion angles C1–S–N–C7 of  80°
(corresponding angle O1–S–N–LP  180°, LP = lone pair) named by
us conformation BC*; (d) orientation of the analogous carbonyl
group of 11 and methylene group of 12 is defined by torsion angles
CROATICA CHEMICA ACTA CCACAA 74 (3) 667¿682 (2001)
* Dedicated to Professor Smiljko A{perger on the occasion of his 80th birthday.
** Author to whom correspondence should be addressed. (E-mail: miljenko.dumic@pliva.hr)
C1–C0–N1–C7 of –78.3 (9)° and –93.9 (5)° respectively; (e) nitrogen
atom in all studied N-sulphonyl-, acyl- and alkyl- aziridines is sp3
hybridised, in contrast to other sulphonamides where sp2 hybridi-
sation is predominant; (f) nitrogen atom in alkylaziridine 12 is
more pyramidal in relation to N-sulphonyl and N-acyl derivatives,
and according to torsion angles O5–N2–C4–C5, the nitro group in
all studied compounds is approximately coplanar to the phenyl
ring plane. Obtained data will serve for further investigation of
steric and electronic properties of studied compounds aimed at de-
signing more antihyperglycaemically potent analogues.
Key words: 1,3-dioxepins, antihyperglycaemic activity, N-sulphonyl-
1a,2,6,6a-tetrahydro-1H,4H-[1,3]dioxepino[5,6-b]azirines, nitroaryl
analogues, regio and stereocontrolled syntheses.
INTRODUCTION
In the context of our research into hypoglycaemically active 1-sulphonyl-
1a,2,6,6a-tetrahydro-1H,4H-1,3dioxepino5,6-bazirines,2–6 the lead compound
1-(4-acetylaminobenzene)sulphonyl-1a,2,6,6a-tetrahydro-1H,4H-1,3dioxepi-
no5,6-bazirine (1) showed the best antihyperglycaemic profile.5
In order to study the importance of the sulphonyl moiety for antihyper-
glycaemic activity profiles, we decided to study the conformational behaviour
of different sulphonyl-, carbonyl- and methylene moieties in the analogues
of 1. Therefore, we would like to report the synthesis of novel nitrophenyl
analogues of 1: N-sulphonylcycloheptabazirine 6, N-sulphonyldioxepino-
azirines 7–10, N-benzoyldioxepinoazirine 11 and N-benzyldioxepinoazirine
12 (Scheme 1), and the basic set of conformational data obtained from their
crystallographic analysis, which will encourage further molecular modelling
studies of isosterism and biosterism between sulphonyl-, carbonyl- and
methylene moieties.
EXPERIMENTAL
Melting points were determined using a Fischer-Johns apparatus, and are un-
corrected. Infrared spectra (IR) were recorded on a Nicolet Magna-IR 760 Spectro-
meter and the bands are given in cm–1. Nuclear magnetic resonance spectra (1H NMR
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(i) 4-NO2-C6H4SO2N3 / acetonitrile, refl., 6.5 h
(ii) TPP / DEAD / acetonitrile, r.t., 0.5–2 h
(iii) 2-, 3- or 4- NO2-C6H4SO2NH2 / pyridine, 130 °C, 15 min
(iv) KOH / H2O, refl., 27 h (Ref. 4)
(v) 4-NO2-C6H4SO4Cl, 4-NO2-C6H4COCl or 4-NO2-C6H4CH2Br / pyridine / CH2Cl2,
0 °C, r.t. or refl., 1–5 h
(vi) NaN3 / aq. acetone, refl., 6 h (Ref. 6); TPP / acetonitrile, refl. 5 h
Scheme 1.
and 13C NMR) were recorded with tetramethylsilane as internal standard on BRUKER
AVANCE DPX 300 and BRUKER AVANCE DRX 500 spectrometers. DMSO-d6 was
used as solvent, unless otherwise stated. Chemical shifts () are given in ppm rela-
tive to the tetramethylsilane ( = 0), and coupling constants (J) in Hz. Combustion
analyses were performed in our laboratory. TLC was performed using Merck
Kieselgel 60 F254 silica plates and components were visualised using UV light and
iodine vapour. Solvents were p.a. grade and were used without further purification.
trans-6-Acetylamino-2-isopropyl-5-chloro-1,3-dioxepane (13)11 and 5,6-epoxi-1,3-di-
oxepane (14)6 were prepared previously. Chemical yields were not optimised.
trans-6-(2-Nitrobenzenesulphonamido)-1,3-dioxepan-5-ol (3)
A mixture of epoxydioxepane 14 (116 mg, 1.0 mmol), pyridine (0.10 mL, 1.2 mmol)
and 2-nitrobenzenesulphonamide12 (202 mg, 1.0 mmol) was heated in a sealed tube
at 130 °C for 15 minutes. After cooling to room temperature, the mixture was puri-
fied by column chromatography using ethyl acetate/petroleum ether (volume ratio 7 : 3)
as eluent. Unreacted starting nitrobenzenesulphonamide (71.0 mg, m.p. 185–187 °C;
lit.15 m.p. 190–191 °C) was obtained from the first fractions. By evaporation of sub-
seqment fractions, the crude, TLC pure, sulphonamidodioxepanol 3 (103.0 mg, 32.4%)
was isolated as a yellow oil. The analytical sample of 3 was prepared by crystallisa-
tion from isopropanol / petroleum ether (vol. ratio 1 : 1); m.p. 108–111 °C.
IR (KBr) nmax/cm–1: 3564, 3509, 3242, 2945, 2901, 1595, 1547, 1455, 1363, 1340,
1304, 1250, 1218, 1168, 1149, 1120, 1071, 1031, 956, 925, 858, 829, 785, 743, 730,
696, 655. 1H NMR (500 MHz, CDCl3) /ppm: 8.20–8.16 (m, 1H, H-C6’), 7.90–7.88 (m,
1H, H-C3’), 7.78–7.74 (m, 2H, H-C5’ and H-C4’), 6.05 (d, 1H, NH, J = 7.9 Hz), 4.76
and 4.69 (ABq, 2H, H-C2, J = 4.5 Hz), 3.87 and 3.84 (2dd, 2H, H-C4, J = 13.0 Hz,
J = 2.0 Hz), 3.83–3.79 (m, 1H, H-C5), 3.55–3.54 (m, 1H, H-C6), 3.83–3.79 (m, 1H,
H-C7) and 3.47 (dd, 1H, H-C7, J = 12.5 Hz, J = 1.6 Hz), 2.62 (br, 1H, OH). 13C NMR
(CDCl3) /ppm: 147.00 (s), 134.05 (d), 133.37 (s) 132.62 (d), 129.83 (d), 124.00 (d)
(C-arom), 93.38 (t, C2), 71.20 (d, C5), 66.88 (t, C4), 64.40 (t, C7), 58.76 (d, C6). MS
(ESI): 341.1 (M+Na)+.
Anal. Calcd. for C11H14N2O7S (Mr = 318.31): C 41.51, H 4.43, N 8.80%; found: C
41.52, H 4.22, N 8.61%.
trans-6-(3-Nitrobenzenesulphonamido)-1,3-dioxepan-5-ol (4)
A mixture of epoxydioxepane 14 (116.0 mg, 1.0 mmol), pyridine (0.1 mL, 1.2 mmol)
and 3-nitrobenzenesulphonamide12 (202.0 mg, 1.0 mmol) was heated in a sealed tube
at 130 °C for 15 minutes. After cooling to room temperature, the mixture was puri-
fied by column chromatography using ethyl acetate/petroleum ether (volume ratio
7 : 3) as eluent. Unreacted starting nitrobenzenesulphonamide (40.0 mg, m.p. 158–
161 °C; lit.15 m.p. 162 °C) was obtained from the first fractions. By evaporation of
subsequent fractions, the crude, TLC pure, sulphonamidodioxepanol 4 (61.0 mg,
19.2%) was isolated as a thick yellow oil.
IR (KBr) max/cm–1: 3288, 3113, 2933, 1607, 1532, 1455, 1433, 1354, 1286, 1170,
1133, 1091, 1039, 990, 967, 902, 877, 813, 771, 735, 664. 1H NMR (500 MHz, CDCl3)
/ppm: 8.75 (deg dd, 1H, H-C2’, J = 1.9 Hz), 8.46 (dd, 1H, H-C4’, J = 7.9 Hz, J = 1.9
Hz), 8.24 (dd, 1H, H-C6’, J = 7.9 Hz, J = 1.9 Hz), 7.77 (deg dd, 1H, H-C5’, J = 7.9 Hz),
5.51 (d, 1H, NH, J = 8.4 Hz), 4.73 and 4.69 (ABq, 2H, H-C2, J = 18.0 Hz, J = 4.6 Hz),
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3.85–3.80 (m, 3H, H-C4 and H-C5), 3.79 and 3.40 (2  dd, 2H, H-C7, J = 3.3 Hz, J =
1.3 Hz, J = 1.3 Hz), 3.43–3.41 (m, 1H, H-C6), 2.18 (s, OH). 13C NMR (CDCl3) /ppm:
147.98 (s), 142.41 (s), 132.17 (d), 130.43 (d), 127.01 (d), 121.84 (d) (C-arom.), 93.68 (s,
C2), 71.58 (d, C5), 65.32 (t, C4), 62.94 (t, C7), 57.05 (d, C6). MS (ESI): 341.0 (M+Na)+.
Anal. Calcd. for C11H14N2O7S (Mr = 318.31): C 41.51, H 4.43, N 8.80%; found: C
41.34, H 4.66, N 8.85%.
trans-6-(4-Nitrobenzenesulphonamido)-1,3-dioxepan-5-ol (5)
A mixture of epoxydioxepane 14 (116.0 mg, 1.0 mmol), pyridine (0.1 mL, 1.2 mmol)
and 4-nitrobenzenesulphonamide12 (202 mg, 1.0 mmol) was heated in a sealed tube
at 130 °C for 15 minutes. After cooling to room temperature, the mixture was purified
by column chromatography using ethyl acetate/petroleum ether (volume ratio 7 : 3)
as eluent. Unreacted starting nitrobenzenesulphonamide (59.0 mg, m.p. 174–175 °C;
lit.15 m.p. 177–178 °C) was obtained from the first fractions. By evaporation of sub-
sequent fractions the crude, TLC pure, sulphonamidodioxepanol 5 (55.0 mg, 17.3%,
m.p. 117–119 °C) was isolated. The analytical sample of 5 was prepared by recrystal-
lisation from ethyl acetate/petroleum ether (vol. ratio 1 : 1); m.p. 120–122 °C.
IR (KBr) max/cm–1: 3550, 3195, 2935, 2899, 1609, 1526, 1458, 1435, 1404, 1352,
1311, 1295, 1235, 1217, 1166, 1133, 1087, 1036, 990, 970, 905, 854, 798, 762, 738,
686, 661, 614. 1H NMR (500 MHz, DMSO-d6) /ppm: 8.39 and 8.09 (2d, 4H, H-arom,
J = 8.9 Hz), 8.23 (d, 1H, NH, J = 1.9 Hz), 4.90 (d, 1H, OH, J = 5.8 Hz), 4.60 (s, 2H,
H-C2), 3.67 and 3.38 (2  dd, 2H, H-C7, J = 12.0, J = 7.1, J = 2.9 Hz), 3.64 and 3.45
(2  dd, 2H, H-C4, J = 12.0, J = 6.8, J = 2.7 Hz), 3.33–3.30, (m, 1H, H-C5), 3.13 (br,
1H, H-C6). 13C NMR (DMSO-d6) /ppm: 149.46 (s), 147.53 (s), 128.16 (d), 124.45 (d)
(C-arom), 93.44 (t, C2), 71.44 (d, C6), 66.97 (t, C7), 64.94 (t, C4), 59.09 (d, C5). MS
(ESI): 340.9 (M+Na)+.
Anal. Calcd. for C11H14N2O7S (Mr = 318.31): C 41.51, H 4.43, N 8.80%; found: C
41.75, H 4.22, N 8.69%.
1-Nitrobenzenesulphonylcycloheptabazirine (6)
A mixture of 4-nitrobenzenesulphonazide (0.91 g, 4 mmol) and cycloheptene (2.33
mL, 20 mmol) in dry acetonitrile (10 mL) was refluxed for 6.5 hours. After evapora-
tion of the solvent under reduced pressure, the mixture was chromatographed in pe-
troleum ether/ethyl acetate (volume ratio 8 : 2) mixture. Concentration of selected
fractions yielded azirine 6 (0.1997 g, 16.9%) as a yellow oil. After crystallisation from
diethyl ether, the analytical sample of 6 was obtained; m.p. 115–118 C. Besides 6,
4-nitrobenzenesulphonylamide was isolated (0.66 g, 81%); m.p. 175–180 C.12
IR (KBr) max/cm–1: 3105, 2926, 2853, 1945, 1810, 1693, 1608, 1530, 1479, 1453,
1422, 1402, 1350, 1319, 1306, 1271, 1222, 1158, 1088, 1034, 966, 941, 855, 842, 807,
788, 753, 743, 702, 682, 622. 1H NMR (300 MHz, DMSO-d6) /ppm: 8.45 and 8.19 (2d,
4H, H-arom, J = 9.2 Hz), 3.03–3.10 (m, 2H, H-C1a,6a), 1.74–1.88 (m, 4H, H-C2,6),
1.14–1.51 (m, 6H, H-C3,4,5). 13C NMR (DMSO-d6) /ppm: 150.61 (s), 143.92 (s), 129.13
(d), 125.01 (d) (C-arom), 44.87 (d, C1a,6a), 30.36 (t, C-2,6), 27.37 (t, C3,5), 24.76 (t,
C4).
Anal. Calcd. for C13H16N2O4S (Mr = 296.34): C 52.69, H 5.44, N 9.45%; found: C
52.80, H, 5.35, N 9.59 %.




A solution of diethyl azodicarboxylate (38% in toluene, 0.72 mL, 1.5 mmol) in 2.0
mL of dry acetonitrile was added dropwise to a solution of nitrobenzenesulphonamido-
dioxepanol 3 (160.0 mg, 0.5 mmol) and triphenylphosphine (405.0 mg, 1.5 mmol) in
8.0 mL of dry acetonitrile at 0 °C during 30 minutes. The mixture was warmed up to
room temperature, stirred for further 2 hours at the same temperature and concen-
trated under reduced pressure. The oily residue was purified by column chromato-
graphy using methylene chloride / methanol (vol. ratio 9 : 1) as eluent, which yielded
crude 7 (90.0 mg, 60.0%) as a solid; m.p. 134–136 °C. The analytical sample of 7 was
prepared by recrystallisation from ethyl acetate / methanol (vol. ratio 6 : 1); m.p.
141–142 C.
IR (KBr) max/cm–1: 2980, 1590, 1550, 1440, 1365, 1335, 1300, 1250, 1170, 1160,
1130, 1105, 1070, 1030, 990, 960, 940, 920, 860, 830, 790, 770, 750, 735, 715, 685. 1H
NMR (300 MHz, DMSO-d6) /ppm: 7.94–8.04 (m, 2H, H-C4’ and H-C5’), 8,23 and
8,21 (2d, 1H, H-C3’, J = 1.8 Hz), 8.21 and 8.12 (2d, 1H, H-C6’, J = 1.8 Hz), 4.81 and
4.34 (2d, 2H, H-C4, J = 7.0 Hz), 3.37 (s, 2H, H-C6a and H-C1a), 4.15 and 4.02 (2d,
4H, H-C6 and H-C2, J = 13.7 Hz). 13C NMR (DMSO-d6) /ppm: 136.00 (s), 133.50 (s),
131.04 (d), 130.45 (d), 125.89 (d) (C-arom), 97.64 (t, C4), 66.05 (t, C2 and C6), 46.34
(d, C1a and C6a). MS (FAB): 301 (M+H)+.
Anal. Calcd. for C11H12N2O6S (Mr = 300.29): C 43.99, H 4.03, N 9.33%; found: C
44.12, H 4.25, N 9.42 %.
Procedure 2
A mixture of azirine 15 (0.19 g, 1.68 mmol), 2-nitrobenzenesulphonyl chloride
(0.45 g, 2.0 mmol), pyridine (0.23 mL, 2.8 mmol) and methylene chloride (7 mL) was
stirred at 0 C for 1 hour. Upon addition of additional 20 mL of methylene chloride,
the mixture was worked up with aqueous NaOH solution (vol. ratio 1 : 1) (2  10 mL).
The organic layer was separated, washed with water (10 mL), neutralised with di-
luted HCl up to pH = 6, washed once more with 10 mL of water and dried over anhy-
drous sodium sulphate. Evaporation of methylene chloride under reduced pressure
yielded crude, TLC pure, sulphonylazirine 7 (0.48 g, 95.1%); m.p. 130–134 C. The
analytical sample of 7 was prepared by recrystallisation from ethyl acetate; m.p.
139–141 C. The IR spectrum of 9 was identical to the IR spectrum of the authentic




A solution of diethyl azodicarboxylate (38% in toluene, 1.44 mL, 3.0 mmol) in 5.0
mL of dry acetonitrile was added dropwise to a solution of nitrobenzenesulphon-
amidodioxepanol 4 (318.3 mg, 1.0 mmol) and triphenylphosphine (811.0 mg, 3.0 mmol)
in 15.0 mL of dry acetonitrile at 0 °C during 30 minutes. The mixture was warmed
up to room temperature, stirred for a further 3 hours at the same temperature and
concentrated under reduced pressure. The oily residue was purified by column chro-
matography using methylene chloride / methanol (vol. ratio 9 : 1) as eluent which
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yielded crude 8 (250.0 mg, 83.3%) as a solid; m.p. 149–150 °C. The analytical sample
of 8 was prepared by recrystallization from ethyl acetate / methanol (vol. ratio 6 : 1);
m.p. 152–153 C.
IR (KBr) max/cm–1: 3100, 2980, 2960, 2900, 2860, 1610, 1530, 1470, 1450, 1430,
1370, 1350, 1295, 1270, 1260, 1240, 1180, 1160, 1145, 1125, 1105, 1070, 1060, 1020,
995, 955, 940, 930, 920, 880, 830, 820, 775, 740, 720, 675, 660. 1H NMR (300 MHz,
DMSO-d6) /ppm: 8.57 (deg dd, 1H, H-C2’, J = 7.8 Hz), 8.60 (d, 1H, H-C4’, J = 7.8
Hz), 8.57–8.54 (m, 1H, H-C6’), 7.99 (deg dd, 1H, H-C5’, J = 7.8 Hz), 4.79 and 4.30
(2d, 2H, H-C4, J = 7.0 Hz), 4.03 and 3.97 (2d, 4H, H-C6 and H-C2, J = 14.0 Hz), 3.29
(s, 2H, H-C1a and H-C6a). 13C NMR (DMSO-d6) /ppm: 148.38 (s), 139.31 (s), 128.85
(d), 132.07 (d), 133.77 (d), 122.48 (d) (C-arom), 97.68 (t, C4), 66.01 (t, C2 and C6),
45.05 (d, C2 and C6). MS (FAB): 301 (M+H)+.
Anal. Calcd. for C11H12N2O6S (Mr = 300.29): C 43.99, H 4.03, N 9.33%; found: C
44.18, H 3.96, N 9.46%.
Procedure 2
A mixture of azirine 15 (0.29 g, 2.50 mmol), 3-nitrobenzenesulphonyl chloride
(0.67 g, 3.00 mmol), pyridine (0.35 mL, 4.30 mmol) and methylene chloride (7 mL)
was stirred at 0 C for 1 hour. Upon addition of additional 20 mL of methylene chlo-
ride, the mixture was worked up with aqueous NaOH solution (volume ratio 1 : 1)
(2  10 mL). The organic layer was separated, washed with water (10 mL), neutral-
ised with diluted HCl up to pH = 6, washed once more with 10 mL of water and dried
over anhydrous sodium sulphate. Evaporation of methylene chloride under reduced
pressure yielded crude, TLC pure, sulphonylazirine 8 (0.67 g, 89.25%); m.p. 149–150
°C. The analytical sample of 8 was prepared by recrystallisation from ethyl acetate;
m.p. 152–153 C. The IR spectrum of 8 was identical to the IR spectrum of the au-




A solution of diethylazodicarboxylate (38% in toluene, 1.44 mL, 3.0 mmol) in 5.0
mL of dry acetonitrile was added to a solution of nitrobenzenesulphonamidodioxe-
panol 5 (318.3 mg, 1.0 mmol) and triphenylphosphine (811.0 mg, 3.0 mmol) in 15.0
mL of dry acetonitrile at 0 °C during 30 minutes. The mixture was warmed up to
room temperature, stirred for a further 2 hours at the same temperature and con-
centrated under reduced pressure. The oily residue was purified by column chroma-
tography using methylene chloride / methanol (volume ratio 9 : 1) as eluent, which
yielded crude 9 (206.0 mg, 68.6%) as a solid; m.p. 206–207 °C. The analytical sample
of 9 was prepared by recrystallisation from ethyl acetate / methanol (vol. ratio 6 : 1);
m.p. 208–210 C. IR spectrum of 9 was identical to the IR spectrum of the authentic
sample.5
Procedure 2
A mixture of azirine 15 (0.29 g, 2.50 mmol), 4-nitrobenzenesulphonyl chloride (0.67 g,
3.00 mmol), pyridine (0.35 mL, 4.30 mmol) and methylene chloride (7 mL) was stirred
at 0 C for 1 hour. Upon addition of additional 20 mL of methylene chloride, the mix-
ture was worked up with aqueous NaOH solution (volume ratio 1 : 1) (2  10 mL). The
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organic layer was separated, washed with water (10 mL), neutralised with diluted
HCl up to pH = 6, washed once more with 10 mL of water and dried over anhydrous
sodium sulphate. Evaporation of methylene chloride under reduced pressure yielded
crude, TLC pure, sulphonylazirine 9 (0.51 g, 68.00%) m.p. 204–206 C. The analytical
sample of 9 was prepared by recrystallisation from acetone; m.p. 206–208 C. The IR
spectrum of 9 was identical to the IR spectrum of the authentic sample.5
1-(4-Nitrobenzoyl)-1a,2,6,6a-tetrahydro-1H,4H-1,3dioxepino5,6-bazirine (11)
A mixture of 15 (0.58 g, 5.0 mmol), 4-nitrobenzoyl chloride (1.0 g, 5.4 mol),
pyridine (0.8 mL) and methylene chloride (20.0 mL) was stirred at reflux tempera-
ture for 1 hour. Upon addition of an additional 20 mL of methylene chloride, the mix-
ture was worked up with 2  10 mL of aqueous sodium hydroxide solution (1 : 1), the
organic layer was separated, washed with 10 mL of water, neutralised with diluted
hydrochloric acid up to pH = 6, washed once more with 10 mL of water, dried over
anhydrous sodium sulphate and concentrated. The obtained solid residue (1.43 g)
was crystallised from methylene chloride / methanol (volume ratio 1 : 2) mixture fur-
nishing TLC pure nitrobenzoylaziridine 11 (0.80 g, 60.6%) as colourless crystals;
m.p. 177–179 °C. After recrystallisation from methylene chloride / methanol (volume
ratio 1 : 2) mixture, the sample showed m.p. 178–180 °C.
IR (KBr) max/cm–1: 3105, 2990, 2950, 2920, 2760, 1670, 1610, 1510, 1440, 1410,
1360, 1300, 1290, 1270, 1240, 1180, 1150, 1120, 1100, 1050, 1100, 1000, 960, 920,
880, 850, 830, 800, 760, 740, 730. 1H NMR (300 MHz, DMSO-d6) /ppm: 8.38 and
8.10 (2d, 4H, H-arom, J = 8.7 Hz), 4.93 and 4.37 (2d, 2H, H-C4, J = 7.1 Hz), 4.46 and
3.91 (2d, 4H, H-C2,6, J = 13.9 Hz), 3.05 (s, H-C1a,6a, 2H). 13C NMR (DMSO-d6)
/ppm: 176.59 (s, CO), 149.89 (s), 138.32 (s), 130.06 (d) and 124.03 (d) (C-arom),
98.25 (t, C4), 66.97 (t, C2,6), 42.18 (d, C1a,6a). MS (ESI): 286.9 (M+Na)+.
Anal. Calcd. for C12H12N2O5 (Mr = 264.24): C 54.55, H 4.58, N 10.60%; found: C
54.52, H 4.57, N 10.61%.
1-(4-Nitrobenzyl)-1a,2,6,6a-tetrahydro-1H,4H-1,3dioxepino5,6-bazirine (12)
A mixture of 15 (0.70 g, 6.1 mmol), 4-nitrobenzyl bromide (1.44 g, 6.7 mmol),
pyridine (1.2 mL) and methylene chloride (15.0 mL) was stirred at room tempera-
ture for 5 hours. The mixture was washed with water (4  10 mL), the organic layer
was separated, dried over anhydrous sodium sulphate and concentrated. The oily
residue (1.78 g) was crystallised from ethyl acetate furnishing TLC pure nitrobenzyl-
aziridine 12 (0.37 g, 24.2%) as colourless crystals; m.p. 88–91 °C. After recrystal-
lisation from ethyl acetate, the sample showed m.p. 90–92 °C.
IR (KBr) max/cm–1: 3440, 3115, 2952, 2904, 2860, 2806, 1597, 1509, 1450, 1425,
1341, 1290, 1261, 1235, 1182, 1123, 1108, 1060, 1013, 989, 944, 919, 861, 839, 789,
756, 738, 678, 660. 1H NMR (300 MHz, DMSO-d6) /ppm: 8.21 and 7.62 (2d, 4H,
H-arom, J = 8.7 Hz), 4.65 and 4.59 (ABq, 2H, H-C4, J = 6.8 Hz), 4.08 and 3.81 (2d,
4H, H-C2,6, J = 13.2 Hz, J = 4.6 Hz), 3.62 (s, 2H, H-C1a,6a), 2.05 (s, 2H, CH2). 13C
NMR (DMSO-d6) /ppm: 147.92 (s), 146.48 (s), 128.62 (d), 123.45 (d) (C-arom), 98.91
(t, C4), 69.57 (t, C2,6), 61.46 (t, CH2), 44.06 (d, C1a,6a). MS (ESI): 250.9 (MH)+.
Anal. Calcd. for C12H14N2O4 (Mr = 250.25): C 57.59, H 5.64, N 11.19%; found: C
57.56, H 5.45, N 11.30%.
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trans-6-(4-Acetylaminobenzenesulphonamido)-1,3-dioxepan-5-ol (17)
trans-(4-Aminobenzenesulphonylamido)-1,3-dioxepan-5-ol (18) (50.00 mg, 0,17
mmol) was dissolved in 1.0 mL of pyridine and the solution was cooled at 0 °C. Acetic
anhydride was added (0.03 mL, 0.20 mmol) and the mixture was stirred at 0 °C for 7
hours. The reaction mixture was left at –15 °C for 2 days, the solvents were evapo-
rated under reduced pressure and a mixture of dioxepanol 18 and trans-6-(4-acetyl-
aminobenzenesulphonamido)-5-acetoxy-1,3-dioxepane (17) (55.00 mg) was obtained.
The crude reaction mixture was chromatographed in ethylacetate / methanol mixtu-
re (volume ratio 9.5 : 0.5) and pure 17 was obtained (23.00 mg, 40.24%) as a white
solid; m.p. 189–191 C (lit. m.p. 209–211 C). Its IR spectrum corresponds to litera-
ture data.6
Besides dioxepanol 17, a mixture of dioxepanol 17 and diacetyl-derivative was
obtained (26 mg).
trans-6-(4-Aminobenzenesulphonamido)-1,3-dioxepan-5-ol (18)
4-Nitrophenyl derivative 5 (100.00 mg, 0.31 mmol) was hydrogenated in ethyl
acetate in the presence of 5% Pd/C catalyst (10.00 mg) under 3 bar hydrogen pres-
sure at room temperature for 2 hours. The catalyst was separated by filtration and
the solvent was evaporated under reduced pressure. The obtained crude oily 18
(99.00 mg) was crystallised from methanol, furnishing TLC pure 18 (78.00 mg, 87.3%);
m.p. 124–126 C. The analytical sample of 18 was prepared by crystallisation from
methanol; m.p. 123–125 C. After recrystallisation from methanol, the sample showed
m.p. 129–130 C.
IR (KBr) max/cm–1: 3471, 3436, 3367, 3262, 3099, 2891, 1650, 1598, 1503, 1462,
1411, 1391, 1312, 1300, 1241, 1185, 1148, 1119, 1089, 1037, 987, 967, 900, 833, 775,
683. 1H NMR (300 MHz, DMSO-d6) /ppm: 7,46 and 6,59 (2d, 4H, H-arom, J = 8.4
Hz), 7,19 (d, 1H, NHSO2, J = 8,1 Hz), 5,93 (s, 2H, NH2), 4,58 (s, 2H, H-C2), 3,69 and
3,47 (ABq, 2H, H-C4, J = 12,3, J = 5,8 Hz), 3,59 and 3,26 (ABq, 2H, H-C7, J = 6 Hz),
3.31 (m, 1H, H-C5), 2,98-2,96 (m, 1H, H-C6). 13C NMR (DMSO-d6) /ppm: 152,70 (s),
128,67 (d), 126,90 (s), 112,83 (d) (C-arom), 93,44 (d, C2), 71,45 (d, C5), 66,97 (t, C4),
64,25 (t, C7) and 58,48 (d, C6). MS (ESI): 210.9 (M+Na)+.
Anal. Calcd. for C11H16N2O5S (Mr = 288.32): C 45.82, H 5.59, N 9.72%; found: C
46.02, H 5.45, N 9.66%.
The X-ray diffraction data for compounds 6 and 8–12 were collected on a
PHILIPS PW1100 automatic four-circle diffractometer (Stoe/Cie upgrade) using gra-
phite monochromatized Mo-K ( = 0.71069 Å) and Cu-K ( = 1.54178 Å) radiation
at room temperature. The measured intensity data were corrected for Lorentz and
polarisation effects, but not for absorption. The molecular and crystal structures
were solved by direct methods implemented in the programs SIR 96 and SHELXS96
and refined on F2 with anisotropic displacement parameters for all non-hydrogen at-
oms. All hydrogen atoms were generated on geometrical grounds. Essential crystal-
lographic data are presented in Table I. Crystallographic data sets for all studied
compounds are deposited with the Cambridge Crystallographic Data Centre and are
available on request. Detailed analysis of molecular geometry will be published else-
where.
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RESULTS AND DISCUSSION
Chemistry
Cycloheptane analogue of 1, N-sulphonylcycloheptabazirine 6 was pre-
pared by addition of 4-nitrobenzenesulphonylazide7 to cycloheptene (2) in
acetonitrile in 17% yield.8 Nitrobenzene derivatives 7–9 were synthesised
via dioxepanols 3–5 by reaction of epoxy derivative 14 with o-, m- and p-
nitrobenzenesulphonamides in sealed tubes at 130 °C, catalysed by pyridine
(17–32%), followed by Mitsunobu cyclisation (60–83%). Before that, deriva-
tive 9 was prepared in 68% yield, by a parallel path, i.e. by sulphonation of
aziridine 15 by p-nitrobenzenesulphonyl chloride.5 Sulphonation of iso-
propyl dioxepin derivative 16, obtained by ring-closure dehydrohalogenation
of the corresponding trans-acetylaminochlorodioxepane 13, furnished only
exo-4-nitrophenyl aziridine 10 in about 90% yield.5 4-Nitrobenzoyl deriva-
tive 11, as well as 4-nitrobenzyl derivative 12 were prepared by reaction of
aziridine 15 with 4-nitrobenzoyl chloride and 4-nitrobenzyl bromide in 61%
and 24% yields, respectively.
Structures of all new nitroaziridine derivatives were assigned from their
spectral data and unambiguously confirmed by the single crystal X-ray
structure analyses (Figure 1, Table I). Unfortunately, an exception was the
o-nitro derivative 7, for which we did not obtain good quality single crystals.
Assignments of the configurations of new sulphonamidodioxepanols 3–5
given in Scheme 1 were based on NMR data and confirmed by an independ-
ent unequivocal two step synthesis of trans-6-(4-acetyl-aminobenzene-
sulphonamido)-1,3-dioxepan-5-ol (17) of the known trans configuration6 by
hydrogenation of 4-nitrophenyl derivative 5, followed by acetylation of the
thus obtained trans-6-(4-aminobenzenesulphonamido)-1,3-dioxepan-5-ol (18).
Finally, the trans-configurations of sulphonamidodioxepanols were indi-
rectly confirmed by single crystal X-ray structure analyses of aziridines 8
and 9 (Figure 1, Table I), obtained by Mitsunobu dehydration9 of 4 and 5.
X-ray Diffraction Study
The thermal ellipsoid plots (TEP) of title compounds 6 and 8–12, with the
atomic numbering scheme, are shown in Figure 1. Crystallographic analy-
ses show that in four out of six solved structures (for 9 and 10 only essential
crystallographic data without deposition were published)5 dioxepinoazirine
and cycloheptabazirine moieties adopt a boat-chair (BC) conformation, and
only in 10 dioxepinoazirine moiety a chair-chair (CC) conformation. In all
the studied cases, the substituent on aziridine nitrogen is always in trans
676 M. ORE[I] ET AL.


























































































































































































































































































































































































































































































































































































































































































































and never in cis position in relation to the cycloheptane or dioxepane ring,
supporting our previous results.5
In addition, the sulphonyl group of sulphonylaziridines 6 and 8–10 adopts
only one of the two possible conformations5 in relation to the aziridine ring,




Figure 1. TEP of 6 and 8–12 crystal structures with atomic numbering. (Ellipsoids




















Figure 2. Sulphonylazirine moiety of 6 and 8–10 adopts only conformation (a) in the
solid state out of the two possible ones, (a) and (b).




















Figure 3. Acylazirine 11 can adopt only one conformation (a). Alkylazirine 12 adopts
conformation (b) in the solid state out of the two possible ones, (b) and (c).
Figure 4. Superposition of crystal state conformations of nitroaziridines 6 and 8–12.
with a torsion angle C1–S–N–C7 of  80° (corresponding angle O1–S–N–LP
 180°; LP = lone pair) (Figure 2a). We named this conformation BC*, and
found it to be the most frequent in the crystal state of sulphonyldioxepino-
azirines.5




Figure 5. Crystal packing of azirines 6 and 8–12. Hydrogen atoms are omitted in
packing diagrams of compounds 8 and 11 for clarity.
Similarly, the orientation of the analogous carbonyl group of 11 is defined
by torsion angle C1–C0–N1–C7 of –78.3(9)° (Figure 3a). Otherwise, the methy-
lene group of 12 adopts only one (Figure 3b) of the two (Figure 3b and 3c)
possible conformations10 in relation to the aziridine ring, with a torsion angle
C1–C0–N1–C7 of –93.9(5)°. Nitrogen atoms in all studied N-sulphonylaziri-
dines are sp3 hybridised, in contrast to other sulphonamides where sp2 hy-
bridisation predominates.10 Similarly, the nitrogen atoms in acylaziridine 11
and alkylaziridine 12 are sp3 hybridised as well, but the latter is more py-
ramidal compared to N-sulphonyl and N-acyl.10 According to torsion angles
O5–N2–C4–C5, the nitro groups in all studied compounds are approximately
coplanar to the phenyl ring plane, as expected. Superposition of sulphonyl-
aziridines 6 and 8–10 illustrates the above conclusions (Figure 4a) and high-
lights their conformational similarity.
Superposition of sulphonyldioxepinoazirine 9 with acyl- 11 and alkyl- 12
analogues (Figure 4b) shows a similarity in the dioxepinoazirine moiety and
overall conformation. However, more conformational heterogeneity is ob-
served in the orientation of the aromatic part of the molecules.
None of the studied molecules possesses H-donating groups or the abil-
ity to form H-bonds. Therefore, all the studied molecules are packed to-
gether in crystals only by van der Waals interactions (Figure 5). Aromatic
parts of molecules usually stick together in dimers.
The described crystallographic and conformational data of the studied
nitro derivatives will serve for further investigation of steric and electronic
properties of the studied compounds and their biosterism, as well as for de-
signing more antihyperglycaemically potent analogues.
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SA@ETAK
Kemija 1,3-dioksepina. XV. Sinteze i struktura
nitroaril-analoga antihiperglikemi~kih
N-sulfonil-1a,2,6,6a-tetrahidro-1H,4H-[1,3]dioksepino[5,6-b]azirina
Marina Ore{i}, Darko Fili}, Biserka Prugove~ki, Mladen Vinkovi}
i Miljenko Dumi}
Opisane su regio- i stereoselektivne sinteze novih nitrofenilnih analoga antihi-
perglikemi~kih N-sulfonil-1a,2,6,6a-tetrahidro-1H,4H-1,3dioksepino5,6-bazirina:
N-nitrobenzensulfonilcikloheptabazirina 6, N-nitrobenzensulfonildioksepinoazirina
7–10, N-nitrobenzoildioksepinoazirina 11 i N-nitrobenzildioksepinoazirina 12, pola-
ze}i od cikloheptena (2), trans-6-acetilamino-2-izopropil-5-kloro-1,3-dioksepana (13) i
5,6-epoksi-1,3-dioksepana (14). Njihovi kristalografski podatci pokazuju: (a) konfor-
macija ~amac-stolac (BC) dominira za dioksepinoazirinski i cikloheptabazirinski dio
molekula; (b) supstituent na aziridinskom du{iku uvijek je u trans-, a nikad u cis-
polo`aju u odnosu na cikloheptanski ili dioksepanski prsten; (c) sulfonilna skupina
sulfonilaziridina 6 i 8–10 zauzima samo jednu od dvije mogu}e konformacije u od-
nosu na aziridinski prsten, s torzijskim kutevima C1–S–N–C7 od  80 (odgovaraju}i
kut O1–S–N–LP  180°, LP = slobodan elektronski par), nazvanu po nama BC*-kon-
formacija; (d) orijentacija karbonilne skupine u 11 i metilenske skupine u 12 defini-
rana je torzijskim kutevima C1–C0–N1–C7 od –78.3 (9)° odnosno od –93.9 (5)°; (e)
du{ikov atom u svim prou~avanim N-sulfonil-, N-acil- i N-alkil-aziridinima je sp3-
hibridiziran za razliku od ostalih sulfonamida, gdje dominira sp2-hibridizacija; (f)
du{ikov atom u alkilaziridinu 12 vi{e je piramidalan nego u N-sulfonil- i N-acil-deri-
vatima; i (g) prema torzijskim kutevima O5–N2–C4–C5 nitro-skupina je u svim pro-
u~avanim spojevima pribli`no koplanarna s fenilnim prstenom.
Dobiveni podatci slu`it }e za daljnja istra`ivanja steri~kih i elektronskih svojsta-
va studiranih spojeva, usmjerena dizajnu antihiperglikemi~ki djelotvornijih analoga.
682 M. ORE[I] ET AL.
